Orient EuroPharma Co., Ltd. (TPEX:4120)
Taiwan · Delayed Price · Currency is TWD 46.90
-0.10 (-0.21%)
Jul 29, 2026, 1:30 PM CST
Orient EuroPharma Market Cap
Orient EuroPharma has a market cap or net worth of 4.07 billion as of July 29, 2026. Its market cap has decreased by -11.68% in one year.
Market Cap
4.07B
Enterprise Value
6.66B
Revenue
4.59B
Ranking
n/a
PE Ratio
n/a
Stock Price
46.90
ChartMarket Cap Chart
Since November 3, 2004, Orient EuroPharma's market cap has increased from 700.81M to 4.07B, an increase of 480.53%. That is a compound annual growth rate of 8.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 4.07B | 4.69% |
| Dec 31, 2025 | 3.89B | -7.05% |
| Dec 31, 2024 | 4.18B | 23.91% |
| Dec 29, 2023 | 3.37B | 7.46% |
| Dec 30, 2022 | 3.14B | -0.41% |
| Dec 30, 2021 | 3.15B | -24.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SCI Pharmtech | 6.20B |
| Formosa Laboratories | 6.16B |
| Orient Pharma | 5.58B |
| Panion & Bf Biotech | 5.24B |
| Easywell Biomedicals | 4.46B |
| LIWANLI Innovation | 4.37B |
| Tien Liang BioTech | 3.61B |
| Yoda Pharmaceuticals | 3.17B |